Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-520-5000
Dr. Bjornstad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Pediatric Endocrinology, 2015 - 2018- University of ColoradoResidency, Pediatrics, 2012 - 2015
Royal College of Surgeons IrelandClass of 2010
Certifications & Licensure
WA State Medical License 2023 - 2028
CO State Medical License 2015 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes Start of enrollment: 2017 Jan 01
- Diabetic Kidney Alarm (DKA) Study Start of enrollment: 2017 Jun 01
- Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study Start of enrollment: 2018 Oct 01
Publications & Presentations
PubMed
- Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks.Hiddo J L Heerspink, Daniel H van Raalte, Katherine Tuttle, David Z I Cherney, Petter Bjornstad
Diabetes, Obesity & Metabolism. 2026-05-01 - Changes in uric acid metabolism and associated plasma proteomics during sex hormone therapy.Sarah A van Eeghen, Danii L S Suijk, Laura L Pyle, Phoom Narongkiatikhun, Ye Ji Choi
Journal of Clinical & Translational Endocrinology. 2026-05-01 - Association of Urinary Epidermal Growth Factor with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.Erik Moedt, Akihiko Koshino, Niels Jongs, Wenjun Ju, Viji Nair
Journal of the American Society of Nephrology. 2026-04-02
Authored Content
- ADA 2018: Dr. Petter Bjornstad on Adioposity, Insulin Resistance and Type 2 Diabetes MellitusJuly 2018
- ADA 2018: Dr. Petter Bjornstad on Adioposity, Insulin Resistance and Type 2 Diabetes MellitusJuly 2018
- Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth with Type 2 DiabetesJune 2018
Press Mentions
- Parkinson's Medication Improved Blood Pressure in Teens with Type 1 DiabetesDecember 6th, 2022
- CU School of Medicine Researcher Brews up Study on Coffee’s Effects on Acute Kidney InjurySeptember 23rd, 2022
- SGLT2 Inhibitors Breathe Life into Kidney-Disease CareAugust 10th, 2022
Grant Support
- KPMP in Type 1 Diabetes: A UW Medicine CollaborationUNIVERSITY OF WASHINGTON2025–2030
- Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and MechanismUNIVERSITY OF COLORADO DENVER2024–2029
- Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant RecipientsUNIVERSITY OF COLORADO DENVER2023–2028
- Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D BiobankUNIVERSITY OF WASHINGTON2024–2027
- Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohortUNIVERSITY OF WASHINGTON2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
